205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-19.42%
Revenue decline while MCHP shows 11.77% growth. Joel Greenblatt would examine competitive position erosion.
1.20%
Cost growth less than half of MCHP's 9.67%. David Dodd would verify if cost advantage is structural.
-49.76%
Gross profit decline while MCHP shows 13.55% growth. Joel Greenblatt would examine competitive position.
-37.64%
Margin decline while MCHP shows 1.59% expansion. Joel Greenblatt would examine competitive position.
-7.62%
R&D reduction while MCHP shows 14.27% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.27%
Operating expenses growth less than half of MCHP's 9.63%. David Dodd would verify sustainability.
1.57%
Total costs growth less than half of MCHP's 9.66%. David Dodd would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
10.42%
D&A growth 50-75% of MCHP's 16.10%. Bruce Berkowitz would examine asset strategy.
-76.74%
EBITDA decline while MCHP shows 14.71% growth. Joel Greenblatt would examine position.
-71.13%
EBITDA margin decline while MCHP shows 2.62% growth. Joel Greenblatt would examine position.
-230.13%
Operating income decline while MCHP shows 16.62% growth. Joel Greenblatt would examine position.
-261.50%
Operating margin decline while MCHP shows 4.33% growth. Joel Greenblatt would examine position.
-53.85%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-180.00%
Pre-tax income decline while MCHP shows 14.85% growth. Joel Greenblatt would examine position.
-199.28%
Pre-tax margin decline while MCHP shows 2.75% growth. Joel Greenblatt would examine position.
-165.56%
Tax expense reduction while MCHP shows 14.86% growth. Joel Greenblatt would examine advantage.
-185.65%
Net income decline while MCHP shows 14.85% growth. Joel Greenblatt would examine position.
-206.30%
Net margin decline while MCHP shows 2.75% growth. Joel Greenblatt would examine position.
-184.62%
EPS decline while MCHP shows 9.09% growth. Joel Greenblatt would examine position.
-184.62%
Diluted EPS decline while MCHP shows 57.14% growth. Joel Greenblatt would examine position.
1.23%
Share count reduction below 50% of MCHP's 0.43%. Michael Burry would check for concerns.
1.23%
Diluted share reduction below 50% of MCHP's 0.21%. Michael Burry would check for concerns.